Regulatory BPC-157: Experimental Peptide Prohibited USADA frames BPC-157 as an experimental peptide prohibited under WADA's S0 unapproved-substances category
Manufactured exclusively by KYOWA HAKKO BIO CO., LTD., a global specialty fermentation company, Kyowas branded ingredients are backed by 60 years of research and innovation to deliver targeted, condition-specific consumer health benefits
These injections are typically administered by healthcare professionals to treat vitamin B12 deficiency in people with pernicious anemia and other conditions, but some clinics offer training for safe self-injection at home
Who Should Consider This Treatment
Peer review Peer review information Nature Reviews Neuroscience thanks Caroline Trumpff and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
It offers targeted respiratory support